Search tool

How is Europe's opioid market evolving? What substances are causing the most concern today? How are countries responding to cannabis use? Find out more when the European Monitoring Centre for Drugs and...

Today, the 59th meeting of the EMCDDA Scientific Committee drew to a close and we said farewell and a heartfelt thank you to its members. For three decades, the Scientific Committee has...

Message from the Director 1/2024 I am delighted to announce today the publication of the latest EMCDDA work programme, which outlines our activities for 2024–2026 . This programme represents a milestone in...

As the curtain falls on 2023, we look back on a year steeped in significance for the EMCDDA. While we commemorated 30 years since the agency's creation, we also prepared for a...

Registration opens today for the next European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2024) taking place in Lisbon from 23–25 October 2024. The multidisciplinary event will showcase cutting-edge scientific research...

EMCDDA Director Alexis Goosdeel is at the European Parliament today where he will be presenting the European Drug Report 2023: Trends and Developments (EDR 2023) to members of the Committee for Civil...

This week, the EMCDDA has launched a call to scientists interested in applying to be on a list of experts who may assist the European Union Drugs Agency (EUDA) in the risk...

Today, the EMCDDA has launched a call for expression of interest in membership of the Scientific Committee of the European Union Drugs Agency (EUDA) . The EUDA, which will replace the EMCDDA...

Representatives of the European Parliament are visiting the EMCDDA this week to discuss how the agency will adapt to its new mandate in 2024. New legislation published on 30 June grants the...

We are delighted to announce that our colleague Laurent Laniel has been presented with the medal of excellence of the Maritime Analysis and Operations Centre-Narcotics (MAOC (N)) . He received the award...